Abstract:BACKGROUND:To search for genes with high sensitivity and to explore its application value related to clinical prognostic prediction, so as to provide important foundation for the preventive intervention, early diagnosis, treatment and prognosis evaluation for breast cancer.METHODS:Tissue samples from ten clinical breast cancer patients were collected to search for the common mutant genes among various samples, and to explore the enrichment degree of mutant genes at both disease and signaling pathway levels using the whole exome sequencing (WES). Subsequently, targets genes with changes in expression levels that showed high correlations with mutation were screened from the above common genes using The Cancer Genome Atlas (TCGA) database. On this basis, differences in the mutation and expression levels of the screened target genes between breast cancer tissues and para-carcinoma tissues, as well as their correlations with patient survival were analyzed using the gene expression and mutation data in TCGA database, together with the clinical information. Finally, the potential regulatory pathways and potential downstream targets of the target genes were predicted through gene set enrichment analysis (GSEA) using Multi-Experiment Matrix (MEM) software.RESULTS:A total of 23 common mutant genes were discovered from the tissue samples from ten breast cancer patients, which were mostly enriched in the cancer, PI3K/Akt and cAMP signaling pathways. Among these 23 genes, only the changes in the expression levels of ZNF384 and PDE4DIP had displayed over 15% consistency with mutation. Besides, it was discovered through TCGA database analysis that, the expression level of ZNF384 gene in breast cancer tissues with ZNF384 mutation was far higher than that in those with no ZNF384 mutation. Moreover, such gene mutation and high expression had shown significantly positive correlation with the patient survival (P<0.05). In addition, GSEA indicated that, tissues with high ZNF384 expression were associated with enrichments related to cell cycle signaling pathway and mitosis metaphase pathway, while this series of effects might be correlated with its regulation on the level and activity of its downstream gene CXCL14.CONCLUSIONS:ZNF384 mutation and up-regulated ZNF384 expression level in breast cancer tissues is significantly positively correlated with patient survival. Therefore, ZNF384 can serve as a molecular marker for the diagnosis and prognostic prediction of breast cancer as well as a potential therapeutic target.

Overexpression of Centromere Protein H is Significantly Associated with Breast Cancer Progression and Overall Patient Survival

Overexpression of Cenp-H As A Novel Prognostic Biomarker for Human Hepatocellular Carcinoma Progression and Patient Survival

Immune Infiltration Related CENPI Associates with the Malignant Features and Drug Resistance of Lung Adenocarcinoma.

Comprehensive Pan-Cancer Analysis Identifies Centromere-Associated Protein E As a Novel Prognostic and Immunological Biomarker in Human Tumors.

Highly expressed CENPL is correlated with breast cancer cell proliferation and immune infiltration

Overexpression of CENPF correlates with poor prognosis and tumor bone metastasis in breast cancer

Overexpression and Mutation of ZNF384 is Associated with Favorable Prognosis in Breast Cancer Patients.

Prognostic Value of Centromere Protein-A Expression in Patients with Epithelial Ovarian Cancer

[Expression and Clinical Significance of Ser10 Phosphorylated P27(kip1) Protein in Human Breast Carcinoma].

High expression of centromere protein A and its molecular mechanism and clinical significance in prostate cancer: A study based on data mining and immunohistochemistry

A pan-cancer landscape of centromere proteins in tumorigenesis and anticancer drug sensitivity

CENPN Acts as a Novel Biomarker that Correlates With the Malignant Phenotypes of Glioma Cells

CENPH Overexpression Promotes the Progression, Cisplatin Resistance, and Poor Prognosis of Lung Adenocarcinoma Via the AKT and ERK/P38 Pathways.

Centromere protein F promotes progression of hepatocellular carcinoma through ERK and cell cycle-associated pathways

The Prognostic Value and Mechanisms of Centromere Protein M in Patients with Lung Adenocarcinoma

Clinical implications and immune features of CENPN in breast cancer

Pan-Cancer and Single-Cell Analysis Reveals CENPL as a Cancer Prognosis and Immune Infiltration-Related Biomarker

Integrative analysis of the expression and prognosis for CENPs in ovarian cancer

CENP-H Regulates the Cell Growth of Human Hepatocellular Carcinoma Cells Through the Mitochondrial Apoptotic Pathway.

Expression and prognostic relevance of centromere protein A in primary osteosarcoma.

Overexpression of centromere protein K (CENP-K) gene in hepatocellular carcinoma promote cell proliferation by activating AKT/TP53 signal pathway.